The Lancet Oncology in conversation with
By The Lancet Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by The Lancet Group
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 15
Reviews: 0
Episodes: 81
Description
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
| Episode | Date |
|---|---|
|
Accelerating equitable cancer genomics and precision oncology with Raffaella Casolino and Mark Lawler
|
Sep 25, 2026 |
|
Tumour-infiltrating lymphocytes in breast cancer with Professor Sherene Loi
|
Aug 24, 2026 |
|
5-year quality of life study of the SUPREMO trial examining chest wall radiotherapy in patients with intermediate-risk breast cancer with Professor Galina Velikova
|
Jul 27, 2026 |
|
Hans Merks on European guidelines for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma
|
Jun 29, 2026 |
|
Hedvig Hricak and Zachary Ward on Cancer workforce—a global crisis: a Lancet Oncology Commission
|
May 31, 2026 |
|
Fred Saad on quality of life in patients with metastatic hormone-sensitive prostate cancer
|
Apr 27, 2026 |
|
James Nagarajah on [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
|
Mar 30, 2026 |
|
Ali Landman on the European Congress of Radiology 2026
|
Mar 17, 2026 |
|
Kayleigh Bhangdia on breast cancer GBD study 2023
|
Mar 09, 2026 |
|
Dylan Graetz and Erica Kaye on qualitative research in oncology
|
Feb 02, 2026 |
|
Jesse Plascak and Marissa Baker on cancer mortality rates by occupation among US workers
|
Dec 29, 2025 |
|
Andre Pfob and Peter Dubsky on The Lucerne Toolbox 3
|
Nov 25, 2025 |
|
Gary Rodin on The human crisis in cancer: a Lancet Oncology Commission
|
Nov 02, 2025 |
|
Matthias Preusser on the phase 2 TUXEDO-3 trial
|
Oct 27, 2025 |
|
Andrea Necchi on TAR-200 plus cetrelimab as neoadjuvant therapy in patients with muscle-invasive bladder cancer
|
Sep 29, 2025 |
|
Linda Bi, Ruchit Patel, Chloe Gui, Farshad Nassiri, and Matija Snuderl on TERT expression and TERT promoter mutations in meningiomas
|
Sep 02, 2025 |
|
Jinming Li on patterns in genomic mutations among patients with early-onset colorectal cancer
|
Jul 28, 2025 |
|
Abdalla Awidi on cancer control in the Middle East
|
Jun 11, 2025 |
|
ASCO 2025 Debrief
|
Jun 11, 2025 |
|
Caroline Robert on treatments for patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN trial)
|
May 28, 2025 |
|
Richard Bryant on transperineal vs transrectal biopsy for prostate cancer
|
Apr 30, 2025 |
|
Professor Amar U. Kishan on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA)
|
Mar 31, 2025 |
|
Ariana Znaor on cancer surveillance in the Eastern Mediterranean region
|
Mar 03, 2025 |
|
Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials
|
Feb 03, 2025 |
|
Yannick Romero on the changing landscape of national cancer control plans
|
Jan 02, 2025 |
|
M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries
|
Dec 02, 2024 |
|
Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma
|
Oct 30, 2024 |
|
Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination
|
Sep 30, 2024 |
|
May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics
|
Sep 30, 2024 |
|
Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02)
|
Aug 27, 2024 |
|
Emmy Boerrigter on dose selection of novel anticancer drugs
|
Jul 29, 2024 |
|
Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations
|
Jun 24, 2024 |
|
Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment
|
May 28, 2024 |
|
James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean
|
Apr 29, 2024 |
|
Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials
|
Apr 08, 2024 |
|
Maria Kyrgiou on innovations in gynaecological cancers and global disparities
|
Mar 07, 2024 |
|
Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers
|
Feb 26, 2024 |
|
Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer
|
Jan 29, 2024 |
|
Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma
|
Jan 02, 2024 |
|
Neerja Bhatla on a new quadrivalent HPV vaccine
|
Nov 29, 2023 |
|
Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery
|
Nov 01, 2023 |
|
Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma
|
Oct 31, 2023 |
|
Wanda Cui on measuring ovarian toxicity
|
Oct 03, 2023 |
|
Ticiana Leal on Tumour Treating Fields
|
Sep 01, 2023 |
|
Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA
|
Aug 02, 2023 |
|
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma
|
Jul 03, 2023 |
|
Madeline Pe on the SISAQOL initiative
|
May 31, 2023 |
|
Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children
|
May 02, 2023 |
|
Mark Lythgoe on UK oncology drug approval after Brexit
|
Mar 27, 2023 |
|
Janet Brown on the phase 2/3 STAR trial
|
Feb 28, 2023 |
|
Valerie Speirs on biomarkers in male breast cancer
|
Jan 30, 2023 |
|
Sameer Bakhshi on sex disparities in childhood cancer in India
|
Jan 03, 2023 |
|
Shankar Siva on radiotherapy for primary renal cell carcinoma
|
Nov 28, 2022 |
|
Mark Lawler and Richard Sullivan on the European Groundshot
|
Nov 15, 2022 |
|
Samar Alhomoud on challenges for cancer control in the Gulf region
|
Oct 31, 2022 |
|
Inge Marie Svane on mRNA vaccines for cancer treatment
|
Sep 27, 2022 |
|
Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer
|
Aug 30, 2022 |
|
Ignace Vergote and Maria Kyrgiou on gynaecological cancers
|
Jul 25, 2022 |
|
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer
|
Jun 30, 2022 |
|
Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa
|
May 09, 2022 |
|
Georgios Lyratzopoulos on emergency presentation
|
Apr 28, 2022 |
|
Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors
|
Mar 29, 2022 |
|
Rosie Bradley on early-stage breast cancer treatment
|
Feb 28, 2022 |
|
Yi-Long Wu and Caicun Zhou on non-small-cell lung cancer
|
Feb 01, 2022 |
|
Rebecca Fitzgerald on Barrett’s oesophagus surveillance
|
Jan 31, 2022 |
|
Elysia Alvarez on adolescent and young adult cancer
|
Dec 29, 2021 |
|
Aju Mathew on cancer care in India
|
Nov 29, 2021 |
|
David Pinato on cancer patients who recovered from SARS-CoV-2 infection
|
Nov 04, 2021 |
|
James Glasbey on the effect of lockdowns on cancer surgery
|
Nov 01, 2021 |
|
Manju Sengar and Christopher Booth on essential cancer drugs
|
Sep 27, 2021 |
|
Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi on helping with cancer control in LMICs
|
Aug 31, 2021 |
|
Harriet Rumgay on the burden of cancer attributable to alcohol
|
Jul 30, 2021 |
|
Rafael Cardoso and Hermann Brenner on colorectal cancer
|
Jun 28, 2021 |
|
Takayuki Yoshino on the DESTINY-CRC01 trial
|
Jun 01, 2021 |
|
Roberto Orecchia on the ELIOT trial
|
Apr 28, 2021 |
|
Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab on nuclear medicine
|
Mar 31, 2021 |
|
Ariana Znaor on breast and cervical cancer in the former Soviet Union
|
Mar 01, 2021 |
|
Sathira Perera on global cancer surgery
|
Jan 21, 2021 |
|
Short-course radiotherapy for advanced rectal cancer
|
Jan 04, 2021 |
|
The crucial role of oncology nurses in cancer care
|
Nov 16, 2020 |
|
The effect of climate change on cancer control
|
Nov 02, 2020 |